CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and resistant hypertension. He ...

For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety ...

Don’t invest unless prepared to lose all the money you invest. This is a high-risk investment, you shouldn’t expect to be protected if something goes wrong.

Ford CEO Jim Farley did not mince words with Wall Street on Tuesday, describing the impact from a lasting 25% tariff as being "devastating." ...

Ford CEO Jim Farley did not mince words with Wall Street on Tuesday, describing the impact from a lasting 25% tariff as being "devastating." ...

While it is not expected that the Inflation Reduction Act will be completely revoked, the elimination of some clean energy ...

Donald Trump's plan to impose new 25% tariffs on steel and aluminium boosted share prices of U.S. producers in pre-market ...

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

Roughly 60,000 federal employees— over 2.5% of the government's workforce have signed up for the president’s deferred ...

A study conducted in the United Kingdom estimated the mutual gains of Net Zero climate policy on the health benefits of air ...

"The question the Leafs or any other potential acquiring team need to ask themselves here: How significantly would a reduction in role impact Granlund's ability to make a positive impact in his ...